Skip to main content

Diagnostic accuracy of left atrial function and strain for differentiating between acute and chronic myocardial infarction



The cardiac magnetic resonance tissue tracking (CMR-TT) technique was used to obtain left atrial strain and strain rate in patients with myocardial infarction (MI) and to evaluate the utility of this technique in the quantitative assessment of myocardial infarction for distinguishing acute from chronic myocardial infarction.


We retrospectively analyzed 36 consecutive patients with acute myocardial infarction (AMI) and 29 patients with chronic myocardial infarction (CMI) who underwent CMR and 30 controls. Left atrial (LA) and ventricular functions were quantified by volumetric, and CMR-TT derived strain analysis from long and short left ventricular view cines. Receiver Operating Characteristics (ROC) analysis was used to determine the diagnostic accuracy of CMR-TT strain parameters for discriminating between acute and chronic myocardial infarction.


AMI and CMI participants had impaired LA reservoir function, conduit function and LA booster pump dysfunction compared to the controls. LA strain was more sensitive than LV global strain for the assessment of the MI stage. Peak late-negative SR yielded the best areas under the ROC curve (AUC) of 0.879, showing differentiation between acute and chronic myocardial infarction of all the LA strain parameters obtained. The highest significant differences between chronic myocardial infarction and normal myocardium were also found in the LV strain (p < 0.001) and LA functional parameters (p < 0.001), but there was no difference between AMI and normals.


CMR-TT-derived LA strain is a potential and robust tool in demonstrating impaired LA mechanics and quantifying LA dynamics, which have high sensitivity and specificity in the differential diagnosis of acute versus chronic myocardial infarction. Their use is thus worth popularizing in clinical application.

Peer Review reports

Myocardial infarction (MI) is caused by a substantial decrease or complete cessation of blood flow to a portion of the myocardium, causing the damaged tissue to be replaced with a fibrotic scar produced by fibroblasts and myofibroblasts. Subsequent compensatory fibrosis of the injured myocardium is prone to systolic and diastolic dysfunction [1]. MI is a significant worldwide burden that accounts for the leading causes of death [2]. Differentiation between acute (AMI) and chronic myocardial infarction (CMI) is clinically significant for patient treatment and follow-up in cases of preexisting CMI, and limited possibility of localizing the acute lesion through ECG or coronary angiography [3]. Late gadolinium enhancement(LGE) is the gold standard for measuring the region and size of myocardial infarction [4]. However, its use in discriminating AMI from CMI is limited.

Cardiovascular magnetic resonance tissue tracking (CMR-TT) technology has been widely used in clinical research and practice for a variety of heart diseases in recent years, which is an approach to assess myocardial deformation from steady-state free precession (SSFP) cine CMR by the tracking of tissue voxel motion [5]. CMR-TT can quantify the early deformation of the left atrium (LA) and ventricle without using contrast agents [6]. It provides a higher spatial resolution and a more extensive field of view, which can reflect the functional characteristics of myocardial tissue more sensitively [7, 8]. Speckle tracking echocardiography (STE) was the first modality to assess atrial strain [9], but it has several limitations, including a suboptimal field of view in the setting of poor acoustic windows and high interobserver variability [10]. Conversely, CMR is a mainstay in the non-invasive assessment of LA volume and function. Several studies have demonstrated that LA deformation detected by CMR-FT can allow for an accurate and reproducible analysis of the LA function [11]. Recently, the importance of LA function and structure has been increasingly acknowledged and led to the introduction of atrial cardiomyopathy as an independent entity [12]. LA modulates LV diastolic filling and cardiac performance during hemodynamic stress or exertion by reservoir, conduit, and booster pump functions [13, 14]. Greater atrial volume is commonly associated with cardiovascular diseases, such as ischemic heart disease, valvular heart disease, and heart failure (e.g., dilated cardiomyopathy) [15]. However, beyond LA volume following AMI, strain and strain rate may be sensitive indicators of left atrial function that have been used to predict cardiovascular mortality [16, 17].

In this study, we aim to compare the impact on LA function between patients with AMI and CMI, as assessed through simultaneous LA and LV structural and functional analyses using CMR-TT, and explore the capability of LA function and strain for distinguishing AMI from CMI.

Materials and methods

Study participants

Between January 2016 and December 2021, 36 consecutive patients with AMI and 29 patients with CMI who received CMR examination at our hospital were retrospectively recruited in this study, with an equal gender and age distribution. Inclusion criteria for patients with AMI were as follows: (1) the patients had to have a first-time AMI with an identified culprit coronary vessel;(2) All patients received successful reperfusion therapy by percutaneous coronary intervention. AMI was diagnosed by history, electrocardiographic changes, cardiac biomarker abnormalities, and coronary angiography following the consensus of the American College of Cardiology and the European Society of Cardiology [18]. The inclusion criteria for CMI: (1) severe chest pain with a duration longer than 30 min; (2) definite MI history and the patients were treated with reperfusion therapy utilizing primary percutaneous coronary intervention longer or equal to 6 months; (3) confirmed of coronary artery stenosis by digital subtraction angiography or computed tomography angiography examination. Exclusion criteria were (1) severe chronic kidney disease; (2) known cardiomyopathy; (3) prior cardiac surgery, severe claustrophobia; (4) gadolinium allergy, and (5) ferrous metallic implants. Twenty-nine healthy subjects without any cardiovascular disease symptoms and with normal electrocardiogram (ECG) results were included. This study was approved by our hospital’s committee, and written informed consent was waived because it is a retrospective study.

Cardiac MRI protocol

Study participants underwent cardiac MRI with clinical 1.5T scanners. We obtained tissue characterization and function in two- and four-chamber long-axis views and short-axis images of the left ventricle with cardiac vector ECG and respiratory gating for scanning. The scan parameters of cine images of Philips Achieva were: TR/TE = 3.38/1.69 ms, FOV: 69.8 cm×32 cm; layer thickness 8 mm, layer interval 2 mm, matrix 192 × 180, and flip angle 60°. Gadopentetate glucosamine (Gd-DTPA) was used as the contrast agent at a dose of 0.2 mmol/kg and an infusion rate of 2.0 ml/s. After the contrast agent was injected, 20 ml of saline was injected at the same rate, and delayed enhancement scans of the heart were done 15 min after the contrast agent was injected intravenously. The delayed enhancement scan parameters were TR/TE = 6.12/3.00 ms, layer thickness 8 mm, layer spacing 2 mm, matrix 152 × 200.

CMR analysis

All CMR analysis was performed offline using commercially available software (CVI42 version 5.12.4, Circle Cardiovascular Imaging, Calgary, Canada). The left ventricular function parameters were performed by drawing out the endo- and epicardial border on LV short-axis cine images (papillary muscles were excluded). The software automatically tracked the displacement of the endocardium and epicardium to quantify the left ventricular myocardium movement. And then, the LV end-diastolic volume (LVEDV), LV end-systolic volume (LVESV), LV ejection fraction (LVEF), LV cardiac output (CO), LV cardiac index (CI), and LV mass (LVM) were well obtained. LV strain values were acquired by autonomously tracking the deformation of myocardial motion during the cardiac cycle, including left ventricle global peak strain radial (LV-GPSr), left ventricle global peak strain circumferential (LV-GPSc) and left ventricle global peak strain longitudinal (LV-GPSl). LGE was taken as the golden standard to identify infarcted segments. Infarct size was defined as the hyper-enhanced area with a signal intensity threshold ≥ 5 standard deviations (SD) above the remote myocardium’s mean signal intensity.

LA volumetric indices were measured by semi-automated tracing of the LA endocardial and epicardial border in end-systole and end-diastole in long-axis two- and four-chamber views excluding pulmonary veins and the LA appendage. Maximum LA volumes were assessed in ventricular end-systole (LAVmax), at ventricular diastole before atrial contraction (LAVpac), and at late ventricular diastole after atrial contraction (LAVmin). Left atrial fractions were defined as fractional volume changes according to the following equations: LA total EF = (LAVmax − LAVmin) × 100%/LAVmax, LA passive EF = (LAVmax − LAVpre-a) × 100%/LAVmax, LA active EF = (LAVpre-a − LAVmin) × 100%/LAVpre-a. The software automatically derived the strain and strain rate values for each tissue point and was represented as a strain curve from which LA strain and strain rate for each period were recorded (Fig. 1). The following LA global functional parameters were quantitatively analyzed: reservoir function (total ejection fraction [LA total EF], total strain [εs], peak positive strain rate [SRs]), conduit function (passive ejection fraction [LA passive EF], passive strain [εe], peak early-negative SR [SRe]), and booster pump function (active ejection fraction [LA active EF], active strain [εa], late peak negative SR [SRa]). LGE was taken as the golden standard to identify infarcted segments.

Fig. 1
figure 1

Male, 56 year, LA measurements by CMR feature tracking. (A and B) LA longitudinal strain in the four- and two-chamber views at end-diastole. (C and D) The LA strain and strain rate curve. Global endocardial LA strain and strain rate values were recorded. εs, reservoir strain; εa, booster strain; εe, conduit strain; εe = εs-εa. SRs, peak positive strain rate;SRe, peak early-negative SR; SRa, peak late-negative SR.


The intra- and inter-observer variability for the LA volume, strain, and SR measurements were assessed by the intraclass correlation coefficient (ICC) in 20 randomly selected subjects (10 healthy subjects and 10 MI patients). Intra-observer reproducibility was established by the same observer who re-analyzed the same 20 subjects after 1 Month. Inter-observer reproducibility was assessed by two investigators blinded to each other’s results.

Statistical analysis

SPSS version 26.0 (IBM, Armonk, NY, USA) was used for statistical analyses. Normally distributed continuous variables were verified using Kolmogorov–Smirnov test. Measurement data were expressed as mean ± SD. Categorical variables were compared using Fisher’s exact test or χ2 tests. Comparisons of continuous variables among three groups were performed using one-way analysis of variance (ANOVA), followed by the Tukey or Games-Howell post hoc pairwise comparison test, respectively. Categorical variables were expressed as numbers and percentages. Independent samples t-test was used to compare the global left ventricular strain and Infarct volume in patients with AMI and CMI. The Receiver Operating characteristic Curve (ROC) was used to analyze the value of LA strain and strain rate parameters in identifying AMI and CMI. P value < 0.05 indicated a statistically significant difference.


Patient characteristics

Initially, 81 patients were included; however, 11 patients were excluded due to poor image quality, and five patients were dropped because no LGE images were available. In the final study cohort, 36 patients with AMI and 29 patients with CMI were included for analysis in this study with sample size- and sex-matched controls. There were no significant differences in gender or body Mass Index among the three groups. The complete baseline characteristics were shown in Table 1.

Table 1 Baseline clinical characteristics

Left ventricular structural and functional abnormality

As shown in Table 2, patients with CMI had higher LV end-diastolic volume and LV end-systolic volume; and bigger LV mass index than patients with AMI and the controls; controls had greater LVEF than patients with AMI and CMI. No significant difference was noted in LV SV, CO, and CI among these three groups. There was no difference in infarct volume and LV strain between AMI and CMI (Fig. 2).

Table 2 LV function and strain parameters
Fig. 2
figure 2

Independent samples t-test was performed for comparisons of LV global peak strain and infarcted segments between the two groups. Ns means No Significance; *P < 0.05; **P < 0.01; *** P < 0.001


Left atrial dysfunction

As assessed by volumetric changes and deformation indexes, LA volumes and dynamics were compared among the three groups in Table 3. LA pre-contractile volumes, max- and minimum LA volumes were the largest in CMI, followed by patients in AMI and controls(all p < 0.05). The CMI, however, had a lower maximal capacity than acute patients(p = 0.047). LA total EF, passive and active EF showed significantly reduced in CMI cases compared to those in AMI and controls(all p < 0.01). Left atrial reservoir, conduit functional, and booster pump parameters, including strain and strain rate, showed significantly different among these three groups(all p < 0.05) (Figs. 3 and 4).

Table 3 LA volumetric and deformation parameters assessed by CMR-FT
Fig. 3
figure 3

One-way ANOVA with post hoc pairwise comparison test was performed for comparisons of LA function among three groups. Ns means No Significance; *P < 0.05; **P < 0.01; *** P < 0.001

Fig. 4
figure 4

One-way ANOVA with post hoc pairwise comparison test was performed for comparisons of LA strain and strain rate among three groups. Ns means No Significance; *P < 0.05; **P < 0.01; *** P < 0.001

Cardiac MR strain parameters for differentiating between AMI and CMI

Of all the LA strain and strain rate parameters obtained, SRa yielded the best AUC (Fig. 3) of 0.879 for determining between AMI and CMI. When SRa≥-0.817 was taken as the boundary point of diagnosing AMI and CMI, the sensitivity and specificity were 87% and 88%, respectively (Fig. 5).

Fig. 5
figure 5

Graph showing results of ROC analysis for differentiation among three groups. (A) The results of ROC analysis for differentiating the AMI and CMI (the AUCs of Es, Ee, Ea, SRs, SRe, SRa were 0.847, 0.805, 0.79, 0.834, 0.857 and 0.879, respectively); (B) ROC analysis for differentiating between AMI and controls (the AUCs of Es, Ee, Ea, SRs, SRe, SRa were 0.789, 0.762, 0.811,0.671,0.673 and 0.717, respectively); (C) ROC analysis for differentiating between CMI and controls (the AUCs of Es, Ee, Ea, SRs, SRe, SRa were 0.941, 0.932, 0.937; 0.924; 0.924 and 0.947, respectively)


LA volumetric and deformation parameters were reproducible on an intra- and inter-observer level. The CV% and ICC were summarized in Table 4.

Table 4 Reproducibility of the LA strain and function analysis by CMR-FT


The current study investigated the diagnostic accuracy of LA function and strain parameters by CMR-TT for differentiating between AMI and CMI. Our findings demonstrate using quantitative tissue approaches in noncontrast methods can be used to detect the stage of MI. Based on the LA deformation and strain measurement, LA strain and strain rate are the predominant parameters for differentiating AMI from CMI. The results of our study provide several vital advances: (I) there were significant differences in the strain and strain rate parameters among AMI, CMI, and controls; these parameters could be utilized to track the stage of myocardial infarction in MI patients; (II) SRa of LA was the best at differentiating between AMI and CMI, with high diagnostic accuracy in all patients; (III) Patients with acute and chronic myocardial infarction can be identified by LA function parameters; however, there is no difference between the AMI and normal groups; (IV) The left global ventricular strain cannot be utilized the key difference between AMI and CMI. As a result, quantitative measurement of LA strain and strain rate could be a valuable tool for non-invasive evaluation, detection, and differentiation of acute and chronic infarction.

LA function is closely related to changes in overall heart function, which has significance for clinical research. Echocardiographic imaging of myocardial deformation can reveal impairments of LA function. Still, CMR is the “gold standard” for evaluating cardiac morphology and function with high accuracy and repeatability that allows comprehensive evaluation of left atrial structure and function from multiple perspectives [11]. In our cohort, although no differences were noted in LA volumetric parameters between AMI and controls, impaired LA strain is already impaired in AMI patients. There were differences between the three groups in terms of LA strain and strain rate. The area under the ROC curve demonstrates that strain and strain rate have higher diagnostic characteristics for identifying AMI and CMI. The response to an ischemic event has been characterized as a dynamic process. Non-viable infarcted tissue leads to an increase in the cardiac workload of the remaining viable myocardium and subsequently to compensatory hypertrophy [19, 20]. While this compensatory process may be viewed as a positive response to keep blood supply to the systemic circulation, it leads to increasing systolic and diastolic volume [21]. So, we think the impaired LA function may be related to the decreased LV systolic and diastolic function and precede left atrial enlargement and abnormal left longitudinal ventricular function [22]. In terms of LA function, the reservoir and conduit functions contribute the most during early diastole, while the booster pump function is the basis for LV filling during late diastole. Previous studies demonstrated that LA strain could reflect myocardial deformation before the clinically apparent LV functional disorders in AMI [17, 23]. In hypertrophic cardiomyopathy, the impaired LA reservoir strain significantly increases mortality risk and HF development or progression [24, 25]. In the Multi-Ethnic Study of Atherosclerosis (MESA), LA dysfunction preceded HF incidence in the asymptomatic general population, and LA reservoir strain was an independent predictor of HF [26]. Nayyar, D [27] et al. described a compensatory increase in atrial booster pump function in the presence of impaired conduit function after STEMI. LA strain reflects atrial compliance and atrial contractility and relaxation, modulated by the descent of the LV base during systole [28, 29]. Therefore, as an early parameter, LA strain may be more helpful in detecting diastolic alterations before LA enlargement. In this context, it is interesting to speculate that the LA strain obtained from CMR-TT is a potential biomarker for distinguishing AMI from CMI, even though further validation studies are needed.

LA modulates LV diastolic filling and cardiac performance during hemodynamic stress or exertion by reservoir, conduit, and booster pump functions [30]. Preserved LA active function represents a compensatory mechanism to maintain stroke volume and LV filling with mild diastolic dysfunction. Its deterioration reflects the reduction of LA compliance and LV “decompensation” [31]. In this study, AMI patients had lower left atrial volume and ejection fraction than CMI, but there were not statistically different from the normal. After myocardial infarction, the myofibroblasts gradually replaced myocytes, which increased LV stiffness and affected blood flow from the LA into the LV [32]. Within certain limits, contraction of the LA follows the Frank-Starling mechanism, which means that the work of LA contraction depends on the volume before its active contraction preload. LA deformation may be compensation enhanced when the LA preload increases within a certain range [33]. Preserved LA ejection function in AMI patients represents a compensatory mechanism to maintain stroke volume and LV filling with early diastolic dysfunction [34]. CMI may lead to chronic LA myocardial hypoperfusion, which may further impair LA contractility or decrease LA compliance [35].

Left ventricular performance and LVEF are most often quantified to assess cardiac function in cardiovascular diseases [36]. This study revealed that patients with CMI had bigger left ventricular systolic and end-diastolic volumes than patients with AMI and normal controls. However, AMI was not significantly different from the control sample. The remodelling of an ischemic event is characterized by progressive LV enlargement and increased end-diastolic wall stress, which results in a reduced ventricular ejection following a right-ward shift of end-diastolic and end-systolic pressure-volume relations. But these changes are frequently observed late during the illness [37,38,39]. If the left ventricular ejection fraction is preserved, it may not accurately reflect myocardial function [40].

Myocardial strain analysis has been developed as a more accurate evaluation of myocardial deformation, with the potential to overcome the limitations of EF and contribute to assessing global and regional myocardial deformation during the cardiac cycle [41, 42]. Previous studies affirmed the accuracy and validity of CMR-TT in different patient populations [43, 44], including MI patients. Myocardial ischemia can lead to myocardial fibrosis developed, which makes myocardial motion and strain lower [45]. The global strain is an indicator of whole heart function and is not effective in differentiating the AMI and CMI. However, some studies [38, 46] have demonstrated that local strain parameters can distinguish between acute and chronic infarction. It may be that the study was longitudinal. Our study, on the other hand, was a cross-sectional study. Moreover, the local myocardial strain is influenced by several variables (such as local myocardial infarction degree, infarct area, the presence of MVO, etc.) [47]. Its reproducibility is poor, so it was not examined in our study.

This study’s major limitations might be explained by its small sample size and the individual variation between the participants. Larger samples would still be needed to determine the diagnostic threshold and promote the quantitative diagnosis between AMI and CMI afforded by this technology. Secondly, there is no classification of the duration of CMI. It’s probable that the longer it lasts, the more prominent alterations in left cardiac parameters will be. Thirdly, differences in strain measurements caused by various scan machines cannot be excluded.

CMR-TT-derived LA strain is a potential and robust tool in demonstrating impaired LA mechanics and quantifying LA dynamics, which have high sensitivity and specificity in the differential diagnosis of acute versus chronic myocardial infarction, and its use is thus worth popularizing in clinical application.

Data Availability

The data underlying this article will be shared on reasonable request to the corresponding author.


  1. Collet JP, Thiele H, Barbato E, Barthélémy O, Bauersachs J, Bhatt DL, Dendale P, Dorobantu M, Edvardsen T, Folliguet T, et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2021;42(14):1289–367.

    Article  PubMed  Google Scholar 

  2. Virani SS, Alonso A, Benjamin EJ, Bittencourt MS, Callaway CW, Carson AP, Chamberlain AM, Chang AR, Cheng S, Delling FN, et al. Heart Disease and Stroke Statistics-2020 update: a Report from the American Heart Association. Circulation. 2020;141(9):e139–e596.

    Article  PubMed  Google Scholar 

  3. Choi BW. Differentiation of acute myocardial infarction from chronic myocardial scar with MRI. Korean J Radiol. 2006;7(1):1–3.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Sun W, Sun L, Yang F, Zhao X, Cai R, Yuan W. Evaluation of myocardial viability in myocardial infarction patients by magnetic resonance perfusion and delayed enhancement imaging. Herz. 2019;44(8):735–42.

    Article  CAS  PubMed  Google Scholar 

  5. Almutairi HM, Boubertakh R, Miquel ME, Petersen SE. Myocardial deformation assessment using cardiovascular magnetic resonance-feature tracking technique. Br J Radiol. 2017;90(1080):20170072.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Overhoff D, Ansari U, Hohneck A, Tülümen E, Rudic B, Kuschyk J, Lossnitzer D, Baumann S, Froelich MF, Waldeck S, et al. Prediction of cardiac events with non-contrast magnetic resonance feature tracking in patients with ischaemic cardiomyopathy. ESC heart failure. 2022;9(1):574–84.

    Article  PubMed  Google Scholar 

  7. Obokata M, Nagata Y, Wu VC, Kado Y, Kurabayashi M, Otsuji Y, Takeuchi M. Direct comparison of cardiac magnetic resonance feature tracking and 2D/3D echocardiography speckle tracking for evaluation of global left ventricular strain. Eur Heart J Cardiovasc Imaging. 2016;17(5):525–32.

    Article  PubMed  Google Scholar 

  8. Xu J, Yang W, Zhao S, Lu M. State-of-the-art myocardial strain by CMR feature tracking: clinical applications and future perspectives. Eur Radiol. 2022;32(8):5424–35.

    Article  PubMed  Google Scholar 

  9. Jain V, Ghosh R, Gupta M, Saijo Y, Bansal A, Farwati M, Marcus R, Klein A, Xu B. Contemporary narrative review on left atrial strain mechanics in echocardiography: cardiomyopathy, valvular heart disease and beyond. Cardiovasc diagnosis therapy. 2021;11(3):924–38.

    Article  Google Scholar 

  10. Pathan F, Zainal Abidin HA, Vo QH, Zhou H, D’Angelo T, Elen E, Negishi K, Puntmann VO, Marwick TH, Nagel E. Left atrial strain: a multi-modality, multi-vendor comparison study. Eur Heart J Cardiovasc Imaging. 2021;22(1):102–10.

    Article  PubMed  Google Scholar 

  11. Alfuhied A, Kanagala P, McCann GP, Singh A. Multi-modality assessment and role of left atrial function as an imaging biomarker in cardiovascular disease. Int J Cardiovasc Imaging. 2021;37(11):3355–69.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Alfuhied A, Marrow BA, Elfawal S, Gulsin GS, Graham-Brown MP, Steadman CD, Kanagala P, McCann GP, Singh A. Reproducibility of left atrial function using cardiac magnetic resonance imaging. Eur Radiol. 2021;31(5):2788–97.

    Article  PubMed  Google Scholar 

  13. Buggey J, Hoit BD. Left atrial strain: measurement and clinical application. Curr Opin Cardiol. 2018;33(5):479–85.

    Article  PubMed  Google Scholar 

  14. Solomon SD, Biering-Sørensen T. LA strain when Ejection Fraction is preserved: a New measure of diastolic function? JACC Cardiovasc imaging. 2017;10(7):744–6.

    Article  PubMed  Google Scholar 

  15. Peters DC, Lamy J, Sinusas AJ, Baldassarre LA. Left atrial evaluation by cardiovascular magnetic resonance: sensitive and unique biomarkers. Eur Heart J Cardiovasc Imaging. 2021;23(1):14–30.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Kowallick JT, Kutty S, Edelmann F, Chiribiri A, Villa A, Steinmetz M, Sohns JM, Staab W, Bettencourt N, Unterberg-Buchwald C, et al. Quantification of left atrial strain and strain rate using Cardiovascular magnetic resonance myocardial feature tracking: a feasibility study. J Cardiovasc Magn resonance: official J Soc Cardiovasc Magn Reson. 2014;16(1):60.

    Article  Google Scholar 

  17. Schuster A, Backhaus SJ, Stiermaier T, Navarra JL, Uhlig J, Rommel KP, Koschalka A, Kowallick JT, Lotz J, Gutberlet M, et al. Left atrial function with MRI enables Prediction of Cardiovascular events after myocardial infarction: insights from the AIDA STEMI and TATORT NSTEMI trials. Radiology. 2019;293(2):292–302.

    Article  PubMed  Google Scholar 

  18. Di Pasquale G, Lombardi A, Casella G. The redefinition of acute myocardial infarction. Italian heart journal: official journal of the Italian Federation of Cardiology. 2004;5(Suppl 6):9s–18s.

    PubMed  Google Scholar 

  19. Gaasch WH, Zile MR. Left ventricular structural remodeling in health and disease: with special emphasis on volume, mass, and geometry. J Am Coll Cardiol. 2011;58(17):1733–40.

    Article  PubMed  Google Scholar 

  20. Li W. Biomechanics of infarcted left Ventricle-A review of experiments. J Mech Behav Biomed Mater. 2020;103:103591.

    Article  PubMed  Google Scholar 

  21. Alter P, Koczulla AR, Nell C, Figiel JH, Vogelmeier CF, Rominger MB. Wall stress determines systolic and diastolic function–characteristics of heart failure. Int J Cardiol. 2016;202:685–93.

    Article  PubMed  Google Scholar 

  22. Zhou D, Yang W, Yang Y, Yin G, Li S, Zhuang B, Xu J, He J, Wu W, Jiang Y, et al. Left atrial dysfunction may precede left atrial enlargement and abnormal left ventricular longitudinal function: a cardiac MR feature tracking study. BMC Cardiovasc Disord. 2022;22(1):99.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Leng S, Ge H, He J, Kong L, Yang Y, Yan F, Xiu J, Shan P, Zhao S, Tan RS, et al. Long-term Prognostic Value of Cardiac MRI Left Atrial strain in ST-Segment Elevation myocardial infarction. Radiology. 2020;296(2):299–309.

    Article  PubMed  Google Scholar 

  24. Yang F, Wang L, Wang J, Pu L, Xu Y, Li W, Wan K, Yang D, Sun J, Han Y, et al. Prognostic value of fast semi-automated left atrial long-axis strain analysis in hypertrophic cardiomyopathy. J Cardiovasc Magn resonance: official J Soc Cardiovasc Magn Reson. 2021;23(1):36.

    Article  Google Scholar 

  25. Yang Y, Yin G, Jiang Y, Song L, Zhao S, Lu M. Quantification of left atrial function in patients with non-obstructive hypertrophic cardiomyopathy by cardiovascular magnetic resonance feature tracking imaging: a feasibility and reproducibility study. J Cardiovasc Magn resonance: official J Soc Cardiovasc Magn Reson. 2020;22(1):1.

    Article  Google Scholar 

  26. Ledwoch J, Stiermaier T, Fuernau G, de Waha S, Eitel C, Pöss J, Desch S, Schuler G, Thiele H, Eitel I. Prognostic value and determinants of CMR-Derived left atrial function assessed in STEMI. JACC Cardiovasc imaging. 2018;11(1):148–50.

    Article  PubMed  Google Scholar 

  27. Nayyar D, Nguyen T, Pathan F, Vo G, Richards D, Thomas L, Dimitri H, Otton J. Cardiac magnetic resonance derived left atrial strain after ST-elevation myocardial infarction: an independent prognostic indicator. Cardiovasc diagnosis therapy. 2021;11(2):383–93.

    Article  Google Scholar 

  28. Gan GCH, Ferkh A, Boyd A, Thomas L. Left atrial function: evaluation by strain analysis. Cardiovasc diagnosis therapy. 2018;8(1):29–46.

    Article  Google Scholar 

  29. Lange T, Schuster A. Quantification of myocardial deformation applying CMR-Feature-tracking-all about the left ventricle? Curr Heart Fail Rep. 2021;18(4):225–39.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Truong VT, Palmer C, Wolking S, Sheets B, Young M, Ngo TNM, Taylor M, Nagueh SF, Zareba KM, Raman S, et al. Normal left atrial strain and strain rate using cardiac magnetic resonance feature tracking in healthy volunteers. Eur Heart J Cardiovasc Imaging. 2020;21(4):446–53.

    PubMed  Google Scholar 

  31. Cau R, Bassareo P, Suri JS, Pontone G, Saba L. The emerging role of atrial strain assessed by cardiac MRI in different cardiovascular settings: an up-to-date review. Eur Radiol. 2022;32(7):4384–94.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Kawel-Boehm N, Bremerich J. The importance of left atrial function after myocardial infarction. Radiology. 2020;296(2):310–1.

    Article  PubMed  Google Scholar 

  33. Kyhl K, Vejlstrup N, Lønborg J, Treiman M, Ahtarovski KA, Helqvist S, Kelbæk H, Holmvang L, Jørgensen E, Saunamäki K, et al. Predictors and prognostic value of left atrial remodelling after acute myocardial infarction. Open heart. 2015;2(1):e000223.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Aguero J, Galan-Arriola C, Fernandez-Jimenez R, Sanchez-Gonzalez J, Ajmone N, Delgado V, Solis J, Lopez GJ, de Molina-Iracheta A, Hajjar RJ, et al. Atrial infarction and ischemic mitral regurgitation contribute to Post-MI Remodeling of the Left Atrium. J Am Coll Cardiol. 2017;70(23):2878–89.

    Article  PubMed  Google Scholar 

  35. Alasady M, Shipp NJ, Brooks AG, Lim HS, Lau DH, Barlow D, Kuklik P, Worthley MI, Roberts-Thomson KC, Saint DA, et al. Myocardial infarction and atrial fibrillation: importance of atrial ischemia. Circulation Arrhythmia and electrophysiology. 2013;6(4):738–45.

    Article  CAS  PubMed  Google Scholar 

  36. Zhao L, Lu A, Tian J, Huang J, Ma X. Effects of different LVEF assessed by Echocardiography and CMR on the diagnosis and therapeutic decisions of Cardiovascular Diseases. Front Physiol. 2020;11:679.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Emrich T, Halfmann M, Schoepf UJ, Kreitner KF. CMR for myocardial characterization in ischemic heart disease: state-of-the-art and future developments. Eur Radiol experimental. 2021;5(1):14.

    Article  Google Scholar 

  38. Baritussio A, Scatteia A, Bucciarelli-Ducci C. Role of cardiovascular magnetic resonance in acute and chronic ischemic heart disease. Int J Cardiovasc Imaging. 2018;34(1):67–80.

    Article  CAS  PubMed  Google Scholar 

  39. Buffa V, Di Renzi P. CMR in the diagnosis of ischemic heart disease. Radiol Med. 2020;125(11):1114–23.

    Article  PubMed  Google Scholar 

  40. Gosling RC, Al-Mohammad A. The role of Cardiac Imaging in Heart failure with reduced ejection fraction. Cardiac Fail Rev. 2022;8:e22.

    Article  Google Scholar 

  41. Augustine D, Lewandowski AJ, Lazdam M, Rai A, Francis J, Myerson S, Noble A, Becher H, Neubauer S, Petersen SE, et al. Global and regional left ventricular myocardial deformation measures by magnetic resonance feature tracking in healthy volunteers: comparison with tagging and relevance of gender. J Cardiovasc Magn resonance: official J Soc Cardiovasc Magn Reson. 2013;15(1):8.

    Article  Google Scholar 

  42. Amzulescu MS, De Craene M, Langet H, Pasquet A, Vancraeynest D, Pouleur AC, Vanoverschelde JL, Gerber BL. Myocardial strain imaging: review of general principles, validation, and sources of discrepancies. Eur Heart J Cardiovasc Imaging. 2019;20(6):605–19.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Karthikeyan B, Sonkawade SD, Pokharel S, Preda M, Schweser F, Zivadinov R, Kim M, Sharma UC. Tagged cine magnetic resonance imaging to quantify regional mechanical changes after acute myocardial infarction. Magn Reson Imaging. 2020;66:208–18.

    Article  PubMed  Google Scholar 

  44. Muser D, Castro SA, Santangeli P, Nucifora G. Clinical applications of feature-tracking cardiac magnetic resonance imaging. World J Cardiol. 2018;10(11):210–21.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Polacin M, Karolyi M, Eberhard M, Gotschy A, Baessler B, Alkadhi H, Kozerke S, Manka R. Segmental strain analysis for the detection of chronic ischemic scars in non-contrast cardiac MRI cine images. Sci Rep. 2021;11(1):12376.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Huo H, Dai X, Li S, Zheng Y, Zhou J, Song Y, Liu S, Hou Y, Liu T. Diagnostic accuracy of cardiac magnetic resonance tissue tracking technology for differentiating between acute and chronic myocardial infarction. Quant imaging Med Surg. 2021;11(7):3070–81.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Erley J, Starekova J, Sinn M, Muellerleile K, Chen H, Harms P, Naimi L, Meyer M, Cavus E, Schneider J, et al. Cardiac magnetic resonance feature tracking global and segmental strain in acute and chronic ST-elevation myocardial infarction. Sci Rep. 2022;12(1):22644.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references


We appreciate the assistance provided by Chengdu Fifth People’s Hospital’s Department of Radiology.


This study has no funding.

Author information

Authors and Affiliations



All authors made a significant contribution to this study. JXF and YY designed this study and collected the clinical data. JXF, YZ, LYT and WM analyzed the data. JXF and JJ drafted the manuscript. JJ, FB and YY supervised this study and revised the article.

Ethics declarations

The authors declare no competing interests.

Ethics approval and consent to participate.

The study was approved by the Ethics Committee of the Chengdu Fifth People’s Hospital (ethics committee approval number: 2020-037-01). The Chengdu Fifth People’s Hospital ethics committee permitted the use of patient data without informed consent. This study conforms with the principles outlined in the Declaration of Helsinki.

Consent for publication.

Not applicable.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jiang, X., Yan, Y., Yang, Z. et al. Diagnostic accuracy of left atrial function and strain for differentiating between acute and chronic myocardial infarction. BMC Cardiovasc Disord 23, 218 (2023).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: